Dogwood Therapeutics (DWTX) Financials: Revenue & Earnings
DWTX$1.25+0.09 +7.76%
$42.49M
Market Cap
—
P/E
—
Forward P/E
—
Score
Dogwood Therapeutics (DWTX) Financials: Revenue & Earnings
DWTX price $1.25 +0.09 +7.76%
- Ticker
- DWTX
- Price
- $1.25
- Change
- +0.09 +7.76%
- Market cap ?
- $42.49M
- Beta ?
- 1.94
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
DWTX fair value $24.04. Price $1.25. Price is 95% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.15 | — | — |
| 2026-08-13 | -0.34 | -0.14 | — | — |
| 2026-05-14 | -0.15 | -0.22 | — | — |
| 2026-03-18 | -0.26 | -0.86 | — | — |
| 2025-11-06 | -8.20 | -1.23 | — | — |
| 2025-08-13 | -1.99 | -1.26 | — | — |
| 2025-05-08 | -8.45 | -0.77 | — | — |
| 2025-02-26 | -5.90 | -1.36 | — | — |
| 2024-11-07 | -2.05 | -1.18 | — | — |
| 2024-08-08 | -1.25 | -1.58 | — | — |
| 2024-05-09 | -1.75 | -1.00 | — | — |
| 2024-02-29 | -1.50 | -1.75 | — | — |
| 2023-11-13 | -1.50 | -2.25 | — | — |
| 2023-08-10 | -2.00 | -1.25 | — | — |
| 2023-05-11 | -2.00 | -4.00 | — | — |
| 2022-12-31 | -2.79 | — | — | — |
| 2022-11-14 | -7.00 | -11.50 | — | — |
| 2022-06-30 | -11.01 | — | — | — |
| 2022-03-31 | -11.89 | — | — | — |
| 2021-12-31 | -13.54 | — | — | — |
| 2021-09-30 | -12.33 | — | — | — |
| 2021-06-30 | -12.85 | — | — | — |
| 2021-03-31 | -9.18 | — | — | — |
| 2020-12-31 | -31.18 | — | — | — |
| 2020-09-30 | -13.96 | — | — | — |
| 2020-06-30 | -3.39 | — | — | — |
| 2020-03-31 | -2.41 | — | — | — |
| 2019-12-31 | -3.30 | — | — | — |
| 2019-09-30 | -4.20 | — | — | — |
| 2019-06-30 | -2.94 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-26 | Sealbond Ltd | Buy | 4.10M | $1.22 | 5.00M |
| 2026-06-16 | De La Rosa Abel | Buy | 16.80K | $1.50 | 25.20K |
| 2026-06-16 | Thomas John C | Buy | 16.80K | $1.50 | 25.20K |
| 2026-06-16 | Whitley Richard James | Buy | 16.80K | $1.50 | 25.20K |
| 2026-06-16 | Keefer David R | Buy | 16.80K | $1.50 | 25.20K |
| 2026-03-05 | Grosswald Ralph | Buy | 82.50K | $2.86 | 235.95K |
| 2026-03-05 | Walsh Angela | Buy | 82.50K | $2.86 | 235.95K |
| 2026-03-05 | Gendreau Roger Michael | Buy | 82.50K | $2.86 | 235.95K |
| 2026-03-05 | Duncan Gregory Scott | Buy | 330.00K | $2.86 | 943.80K |
| 2025-12-04 | Duncan Gregory Scott | Buy | 460.00K | $6.14 | 2.82M |
| 2025-12-04 | Walsh Angela | Buy | 150.00K | $6.14 | 921.00K |
| 2025-12-04 | Grosswald Ralph | Buy | 150.00K | $6.14 | 921.00K |
| 2025-12-04 | Gendreau Roger Michael | Buy | 150.00K | $6.14 | 921.00K |
| 2025-11-21 | Sealbond Ltd | Buy | 21.61M | $0.00 | 2.16K |
| 2025-11-21 | Sealbond Ltd | Buy | 2.84M | $0.00 | 284 |
| 2025-11-21 | Sealbond Ltd | Sell | 2.16K | — | — |
| 2025-11-21 | Sealbond Ltd | Sell | 284 | — | — |
| 2025-06-27 | Gendreau Roger Michael | Buy | 12.07K | $4.71 | 56.87K |
| 2025-06-27 | Whitley Richard James | Buy | 2.36K | $4.71 | 11.13K |
| 2025-06-27 | Grosswald Ralph | Buy | 12.07K | $4.71 | 56.87K |
| 2025-06-27 | Thomas John C | Buy | 2.36K | $4.71 | 11.13K |
| 2025-06-27 | Duncan Gregory Scott | Buy | 40.00K | $4.71 | 188.40K |
| 2025-06-27 | Keefer David R | Buy | 2.36K | $4.71 | 11.13K |
| 2025-06-27 | Walsh Angela | Buy | 12.07K | $4.71 | 56.87K |
| 2025-06-27 | De La Rosa Abel | Buy | 2.36K | $4.71 | 11.13K |
| 2025-06-18 | Whitley Richard James | Buy | 210 | $4.80 | 1.01K |
| 2025-06-18 | Whitley Richard James | Buy | 210 | $4.80 | 1.01K |
| 2025-06-18 | Keefer David R | Buy | 210 | $4.80 | 1.01K |
| 2025-06-18 | Keefer David R | Buy | 210 | $4.80 | 1.01K |
| 2025-06-18 | Thomas John C | Buy | 210 | $4.80 | 1.01K |
| 2025-06-18 | Thomas John C | Buy | 210 | $4.80 | 1.01K |
| 2025-06-18 | De La Rosa Abel | Buy | 210 | $4.80 | 1.01K |
| 2025-06-18 | De La Rosa Abel | Buy | 210 | $4.80 | 1.01K |
| 2025-03-12 | Conjoint Inc. | Other | 2.84M | — | — |
| 2025-03-12 | CK Life Sciences Intl (Holdings) Inc | Buy | 284 | $7.01 | 1.99K |
| 2024-10-07 | Yu Ying Choi Alan Abel | Other | 0 | — | — |
| 2024-10-07 | Toh Kean Meng Melvin | Other | 0 | — | — |
| 2024-10-07 | Sealbond Ltd | Other | 0 | — | — |
| 2024-10-07 | Sealbond Ltd | Other | 21.08M | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 16, holders +3 vs prior quarter. Ownership 11.22%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 3.13M | -147.51K | -4.50% | 5.04M |
| MILLENNIUM MANAGEMENT LLC | 341.81K | 341.81K | New | 550.32K |
| VANGUARD CAPITAL MANAGEMENT LLC | 132.15K | 0 | 0.00% | 212.77K |
| GEODE CAPITAL MANAGEMENT, LLC | 88.30K | 8.86K | +11.16% | 142.16K |
| VANGUARD FIDUCIARY TRUST CO | 62.74K | 0 | 0.00% | 101.00K |
| BLACKROCK, INC. | 28.55K | 28.52K | +95053.33% | 45.96K |
| NORTHERN TRUST CORP | 23.78K | 0 | 0.00% | 38.28K |
| CITADEL ADVISORS LLC | 11.74K | 11.74K | New | 18.91K |
| TOWER RESEARCH CAPITAL LLC (TRC) | 3.09K | -4.97K | -61.66% | 4.98K |
| MORGAN STANLEY | 2.22K | 2.22K | New | 3.58K |
| UBS GROUP AG | 1.86K | -5.22K | -73.75% | 3.00K |
| MERCER GLOBAL ADVISORS INC /ADV | 550 | 550 | New | 886 |
| JONES FINANCIAL COMPANIES LLLP | 160 | 160 | New | 264 |
| BARCLAYS PLC | 157 | 157 | New | 253 |
| ACTIVEST WEALTH MANAGEMENT | 120 | 0 | 0.00% | 193 |
| GROUP ONE TRADING LLC | 9 | 0 | 0.00% | 14 |
| MARSHALL WACE, LLP | 0 | -11.76K | -100.00% | 0 |
| BNP PARIBAS FINANCIAL MARKETS | 0 | -2 | -100.00% | 0 |
| GOLDMAN SACHS GROUP INC | 0 | -14.60K | -100.00% | 0 |
Earnings and financials
Dogwood Therapeutics, Inc. (DWTX) trades at $1.25, with a market cap of $42.49M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn